In regulatory filings, DiaMedica Therapeutics disclosed that its 10%-holders Thomas Van Koch and Jan Stahlberg each bought 1.2M shares of common stock on June 28th in respective transaction sizes of $3M. Shares of DiaMedica Therapeutics were up 7.5% afterhours at $3.17.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DMAC: